Dr. Matthew Halpert
PhD · Cancer Immunologist
Founder & CEO · Immunocine Cancer Center · Cancún & Cabo San Lucas, Mexico
- Cancer immunologist trained at the University of Alabama at Birmingham and Baylor College of Medicine
- Co-developed the double-loaded dendritic cell technology that powers Immunocine’s treatment
- Author of peer-reviewed research cited hundreds of times in the cancer immunology field
About Dr. Halpert
Dr. Matthew Halpert is a cancer immunologist and the Founder and CEO of Immunocine Cancer Center, a personalized dendritic cell immunotherapy clinic with locations in Cancún and Cabo San Lucas, Mexico.
He is known for helping develop “double-loaded” dendritic cell technology — a method of training a patient’s own immune cells to recognize and attack their specific cancer — and for guiding that research out of the lab and into real-world patient care for those who can’t access or wait for U.S. clinical trials.
Clinical Specialties & Advanced Therapies
Double-Loaded Dendritic Cell Therapy
A personalized immunotherapy that loads a patient’s own dendritic cells with both mRNA and protein antigens from their tumor, training the immune system to target their specific cancer.
Immune System Restoration & Support
Pre-treatment evaluation and support to help ensure a patient’s immune system is stable enough to respond to dendritic cell therapy.
Solid Tumor Immuno-Oncology
Treatment protocols designed for a wide range of biopsiable solid tumor types, administered alongside Immunocine’s medical and oncology team.
Medical Background & Credentials
- PhD in Microbiology and Immunology, University of Alabama at Birmingham (UAB)
- Postdoctoral training and 10 years on faculty at Baylor College of Medicine, Departments of Pathology & Immunology and Molecular and Human Genetics
- Research focus: dendritic cell biology, immune polarization, and mechanisms of durable anti-tumor immunity
- Co-founder and former Chief Technology Officer, Diakonos Oncology (dendritic cell vaccine platform with FDA Fast Track designation in glioblastoma and pancreatic cancer trials)
- Founded Immunocine Cancer Center in 2021 after leaving Baylor College of Medicine
Research & Medical Publications
Media, Podcasts & Interviews
Featured Podcast Episode
Clinical Insights & Shorts
Consult with Dr. Matthew Halpert
Tell us a little about your situation. An advisor will get back to you — free, with no obligation.
- Free for patients — we’re paid by no clinic on this page
- Confidential — your details are never shared without consent
- A real person replies, usually within one business day
